scispace - formally typeset
Search or ask a question
Institution

Lundbeck

CompanyCopenhagen, Denmark
About: Lundbeck is a company organization based out in Copenhagen, Denmark. It is known for research contribution in the topics: Population & Agonist. The organization has 2443 authors who have published 3989 publications receiving 149682 citations. The organization is also known as: H. Lundbeck A/S.


Papers
More filters
Journal ArticleDOI
Stephan Ripke1, Stephan Ripke2, Benjamin M. Neale1, Benjamin M. Neale2  +351 moreInstitutions (102)
24 Jul 2014-Nature
TL;DR: Associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses.
Abstract: Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia.

6,809 citations

Journal ArticleDOI
TL;DR: The basis for the unique properties and rate enhancement for triazole formation under Cu(1) catalysis should be found in the high ∆G of the reaction in combination with the low character of polarity of the dipole of the noncatalyzed thermal reaction, which leads to a considerable activation barrier.
Abstract: The Huisgen 1,3-dipolar cycloaddition reaction of organic azides and alkynes has gained considerable attention in recent years due to the introduction in 2001 of Cu(1) catalysis by Tornoe and Meldal, leading to a major improvement in both rate and regioselectivity of the reaction, as realized independently by the Meldal and the Sharpless laboratories. The great success of the Cu(1) catalyzed reaction is rooted in the fact that it is a virtually quantitative, very robust, insensitive, general, and orthogonal ligation reaction, suitable for even biomolecular ligation and in vivo tagging or as a polymerization reaction for synthesis of long linear polymers. The triazole formed is essentially chemically inert to reactive conditions, e.g. oxidation, reduction, and hydrolysis, and has an intermediate polarity with a dipolar moment of ∼5 D. The basis for the unique properties and rate enhancement for triazole formation under Cu(1) catalysis should be found in the high ∆G of the reaction in combination with the low character of polarity of the dipole of the noncatalyzed thermal reaction, which leads to a considerable activation barrier. In order to understand the reaction in detail, it therefore seems important to spend a moment to consider the structural and mechanistic aspects of the catalysis. The reaction is quite insensitive to reaction conditions as long as Cu(1) is present and may be performed in an aqueous or organic environment both in solution and on solid support.

3,855 citations

Journal ArticleDOI
Naomi R. Wray1, Stephan Ripke2, Stephan Ripke3, Stephan Ripke4  +259 moreInstitutions (79)
TL;DR: A genome-wide association meta-analysis of individuals with clinically assessed or self-reported depression identifies 44 independent and significant loci and finds important relationships of genetic risk for major depression with educational attainment, body mass, and schizophrenia.
Abstract: Major depressive disorder (MDD) is a common illness accompanied by considerable morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide association meta-analysis based in 135,458 cases and 344,901 controls and identified 44 independent and significant loci. The genetic findings were associated with clinical features of major depression and implicated brain regions exhibiting anatomical differences in cases. Targets of antidepressant medications and genes involved in gene splicing were enriched for smaller association signal. We found important relationships of genetic risk for major depression with educational attainment, body mass, and schizophrenia: lower educational attainment and higher body mass were putatively causal, whereas major depression and schizophrenia reflected a partly shared biological etiology. All humans carry lesser or greater numbers of genetic risk factors for major depression. These findings help refine the basis of major depression and imply that a continuous measure of risk underlies the clinical phenotype.

1,898 citations

Journal ArticleDOI
TL;DR: A single family of proteases, the caspases, has long been considered the pivotal executioner of all programmed cell death, but recent findings of evolutionarily conserved, caspase-independent controlled death mechanisms have opened new perspectives on the biology of cell demise.
Abstract: A single family of proteases, the caspases, has long been considered the pivotal executioner of all programmed cell death However, recent findings of evolutionarily conserved, caspase-independent controlled death mechanisms have opened new perspectives on the biology of cell demise, with particular implications for neurobiology, cancer research and immunological processes

1,690 citations

Journal ArticleDOI
Ditte Demontis1, Ditte Demontis2, Raymond K. Walters3, Raymond K. Walters4, Joanna Martin3, Joanna Martin5, Joanna Martin6, Manuel Mattheisen, Thomas Damm Als2, Thomas Damm Als1, Esben Agerbo1, Esben Agerbo2, Gisli Baldursson, Rich Belliveau3, Jonas Bybjerg-Grauholm1, Jonas Bybjerg-Grauholm7, Marie Bækvad-Hansen1, Marie Bækvad-Hansen7, Felecia Cerrato3, Kimberly Chambert3, Claire Churchhouse4, Claire Churchhouse3, Ashley Dumont3, Nicholas Eriksson, Michael J. Gandal, Jacqueline I. Goldstein3, Jacqueline I. Goldstein4, Katrina L. Grasby8, Jakob Grove, Olafur O Gudmundsson9, Olafur O Gudmundsson10, Christine Søholm Hansen7, Christine Søholm Hansen1, Christine Søholm Hansen11, Mads E. Hauberg1, Mads E. Hauberg2, Mads V. Hollegaard1, Mads V. Hollegaard7, Daniel P. Howrigan3, Daniel P. Howrigan4, Hailiang Huang4, Hailiang Huang3, Julian Maller3, Alicia R. Martin3, Alicia R. Martin4, Nicholas G. Martin8, Jennifer L. Moran3, Jonatan Pallesen1, Jonatan Pallesen2, Duncan S. Palmer4, Duncan S. Palmer3, Carsten Bøcker Pedersen1, Carsten Bøcker Pedersen2, Marianne Giørtz Pedersen1, Marianne Giørtz Pedersen2, Timothy Poterba4, Timothy Poterba3, Jesper Buchhave Poulsen7, Jesper Buchhave Poulsen1, Stephan Ripke4, Stephan Ripke12, Stephan Ripke3, Elise B. Robinson4, F. Kyle Satterstrom3, F. Kyle Satterstrom4, Hreinn Stefansson10, Christine Stevens3, Patrick Turley4, Patrick Turley3, G. Bragi Walters10, G. Bragi Walters9, Hyejung Won13, Hyejung Won14, Margaret J. Wright15, Ole A. Andreassen16, Philip Asherson17, Christie L. Burton18, Dorret I. Boomsma19, Bru Cormand, Søren Dalsgaard2, Barbara Franke20, Joel Gelernter21, Joel Gelernter22, Daniel H. Geschwind14, Daniel H. Geschwind13, Hakon Hakonarson23, Jan Haavik24, Jan Haavik25, Henry R. Kranzler26, Henry R. Kranzler22, Jonna Kuntsi17, Kate Langley6, Klaus-Peter Lesch27, Klaus-Peter Lesch28, Klaus-Peter Lesch29, Christel M. Middeldorp15, Christel M. Middeldorp19, Andreas Reif30, Luis Augusto Rohde31, Panos Roussos, Russell Schachar18, Pamela Sklar32, Edmund J.S. Sonuga-Barke17, Patrick F. Sullivan33, Patrick F. Sullivan5, Anita Thapar6, Joyce Y. Tung, Irwin D. Waldman34, Sarah E. Medland8, Kari Stefansson10, Kari Stefansson9, Merete Nordentoft1, Merete Nordentoft35, David M. Hougaard7, David M. Hougaard1, Thomas Werge35, Thomas Werge11, Thomas Werge1, Ole Mors1, Ole Mors36, Preben Bo Mortensen, Mark J. Daly, Stephen V. Faraone37, Anders D. Børglum1, Anders D. Børglum2, Benjamin M. Neale4, Benjamin M. Neale3 
TL;DR: A genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls identifies variants surpassing genome- wide significance in 12 independent loci and implicates neurodevelopmental pathways and conserved regions of the genome as being involved in underlying ADHD biology.
Abstract: Attention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, finding important new information about the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes and around brain-expressed regulatory marks. Analyses of three replication studies: a cohort of individuals diagnosed with ADHD, a self-reported ADHD sample and a meta-analysis of quantitative measures of ADHD symptoms in the population, support these findings while highlighting study-specific differences on genetic overlap with educational attainment. Strong concordance with GWAS of quantitative population measures of ADHD symptoms supports that clinical diagnosis of ADHD is an extreme expression of continuous heritable traits.

1,436 citations


Authors

Showing all 2448 results

NameH-indexPapersCitations
Henrik Kehlet130106976338
Preben Bo Mortensen12165060052
Torben Hansen120105889876
Arne Schousboe9751933871
Benjamin L. Ebert9238183610
Marcel Leist9236127869
Kim F. Michaelsen9151333858
Merete Nordentoft8972336487
Sten Madsbad8753228980
Marja Jäättelä8520542426
Ole Mors8254538833
Poul Nissen8132625153
José Luis Molinuevo7741627009
Thomas Werge7742039165
Thomas Hansen7532733818
Network Information
Related Institutions (5)
Eli Lilly and Company
22.8K papers, 946.7K citations

92% related

AstraZeneca
23.4K papers, 938.2K citations

90% related

Karolinska Institutet
121.1K papers, 6M citations

89% related

GlaxoSmithKline
21.1K papers, 1.1M citations

89% related

Pfizer
37.4K papers, 1.6M citations

89% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20232
20224
2021223
2020208
2019242
2018250